Home » Another Biotech Breakout (Plus Avoiding the “Fool’s Play”)

Another Biotech Breakout (Plus Avoiding the “Fool’s Play”)

Hey, Ross here:

As always, thanks for reading the Stock Surge Daily newsletter. Here’s what’s on the table for today.

Chart of the Day

CymaBay Therapeutics (CBAY) is another biotech stock making a huge move right now.

It is one of the small handful of breakouts that have played out as expected and followed through to the upside.

As of Friday morning, the stock is pulling back to its 10-day exponential moving average.

This is a good low-risk spot to place a long trade with a 6-7% stop.

Insight of the Day

Betting on fickle sentiment is a fool’s play

I told you how quickly the tables can turn. On Friday, the market rallied on hopes the Fed may let up after data showed slowing wage growth and a shrinking service sector. Yesterday, that rally fizzled out after two Fed officials said they saw interest rates rising above 5%.

And with earnings season coming up – one that many believe will be below expectations – don’t be surprised if the next few weeks are painful. Sure, we may see mini-rallies here and there. But don’t bet on them lasting.

Fortunately, the market is just the sum of all individual stocks’ movements. If the market falls, it means that more stocks have fallen than have risen on average. But it doesn’t mean that no stocks have gone up.

That’s how I’ve been able to consistently spot profitable opportunities even in this tough market. Because the “big money” is always moving – you just have to know how to take advantage of them.

More on that here.

Embrace the surge,

Ross Givens

Editor, Stock Surge Daily

Brand New Strategy for Profiting from AI Stocks.

There’s a brand-new strategy in 2024 for going after big profits in AI stocks. It has nothing to do with Nvidia, Microsoft, Meta – or any of the big AI stocks the media can’t stop talking about.

It has to do with a fast-moving “backdoor” that has opened in the AI market... A backdoor that could send a very special class of AI stocks rocketing into the stratosphere.

Ross Givens
Ross Givens

I bought my first stock when I was 12 years old. It was Microsoft. I’ve been a registered financial advisor. I’ve worked as a stock broker. I ran a managed fund. I was a Vice President at JP Morgan with Series 7, Series 66 and Series 3 securities licenses. I’ve been featured on Fox Business, CNBC, Bloomberg, and a bunch of other networks. The only thing I enjoy more than making money, is helping YOU make money.

With Ross Givens

Looking for an edge? Ross has the inside scoop on top analysis that will help grow your portfolio.. Receive a new stock opportunity every day and get ready to see your investment SURGE!

Tech stocks are rallying – and Ross Givens’ #1 Tech Stock of the Decade has been making BIG moves you don’t want to miss.

Whats in the Article